Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

The Movement to Transform Cancer Pathology with AI

Proscia
By Author Proscia | March 11, 2021

AI is playing a tremendous role in cancer diagnostics. Philadelphia, PA-based Proscia builds software and has a platform for imaging workflow management that allows a pathologist in the lab to take digitized images of the glass slides the tissue biopsy sits on and move these images through workflows.

The company uses its computational AI-based applications to find patterns in the imaging and transform that information into something meaningful for the pathologist.

Our website uses cookies. By using this site, you agree to its use of cookies.